Assessment of a strategy combining ambulatory blood pressure, adherence monitoring and a standardised triple therapy in resistant hypertension

被引:3
|
作者
Polychronopoulou, Erietta [1 ,2 ]
Burnier, Michel [1 ,2 ]
Ehret, Georg [3 ]
Schoenenberger-Berzins, Renate [4 ]
Berney, Maxime [1 ,2 ]
Ponte, Belen [5 ]
Erne, Paul [6 ]
Bochud, Murielle [7 ]
Pechere-Bertschi, Antoinette [5 ]
Wuerzner, Gregoire [1 ,2 ]
机构
[1] Lausanne Univ Hosp, Serv Nephrol & Hypertens, Lausanne, Switzerland
[2] Lausanne Univ, CHUV, Lausanne, Switzerland
[3] Geneva Univ Hosp, Cardiol, Geneva, Switzerland
[4] Luzerner Kantonspital, Herzzentrum, Luzern, Switzerland
[5] Univ Hosp, Serv Nephrol & Hypertens, Hypertens Ctr, Geneva, Switzerland
[6] Univ Svizzera Italiana, Fac Biomed Sci, Lugano, Switzerland
[7] Univ Lausanne, Univ Ctr Gen Med & Publ Hlth, Unisante, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
Resistant hypertension; blood pressure control; fixed-dose combination therapy; electronic pill boxes; treatment adherence; MEDICATION ADHERENCE; PREVALENCE; HYDROCHLOROTHIAZIDE; ASSOCIATION; AMLODIPINE; MANAGEMENT; DIAGNOSIS; APPARENT;
D O I
10.1080/08037051.2021.1907174
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose Poor adherence to drug therapy and inadequate drug regimens are two frequent factors responsible for the poor blood pressure (BP) control observed in patients with apparent resistant hypertension. We evaluated the efficacy of an antihypertensive management strategy combining a standardised therapy with three long acting drugs and electronic monitoring of drug adherence in patients with apparent resistant hypertension. Materials and Methods In this multicentric observational study, adult patients with residual hypertension on 24 h ambulatory BP monitoring (ABMP) despite the use of three or more antihypertensive drugs could be included. Olmesartan/amlodipine (40/10 mg, single pill fixed-dose combination) and chlorthalidone (25 mg) were prescribed for 3 months in two separated electronic pills boxes (EPB). The primary outcome was 24 h ambulatory systolic BP (SBP) control at 3 months, defined as mean SBP Results We enrolled 48 patients (36.0% women) of whom 35 had complete EPB data. After 3 months, 52.1% of patients had 24 h SBP <130 mmHg. 24 h SBP decreased by respectively -9.1 +/- 15.5 mmHg, -22.8 +/- 30.6 mmHg and -27.7 +/- 16.6 mmHg from the tertile with the lowest adherence to the tertile with the highest adherence to the single pill combination (p = 0.024). A similar trend was observed with tertiles of adherence to chlorthalidone. Adherence superior to 90% was associated with 24 h systolic and diastolic blood pressure control in multiple logistic regression analysis (odds ratio = 14.1 (95% confidence interval 1.1-173.3, p = 0.039). Conclusions A simplified standardised antihypertensive therapy combined with electronic monitoring of adherence normalises SBP in about half of patients with apparent resistant hypertension. Such combined management strategy enables identifying patients who need complementary investigations and those who rather need a long-term support of their adherence.
引用
收藏
页码:332 / 340
页数:9
相关论文
共 50 条
  • [41] In-Clinic Blood Pressure Prediction of Normal Ambulatory Blood Pressure Monitoring in Pediatric Hypertension Referrals
    Johnson, Philip K.
    Ferguson, Michael A.
    Zachariah, Justin P.
    CONGENITAL HEART DISEASE, 2016, 11 (04) : 309 - 314
  • [42] Mortality risks in different subtypes of masked hypertension in the Spanish ambulatory blood pressure monitoring registry
    de la Sierra, Alejandro
    Ruilope, Luis M.
    Staplin, Natalie
    Stergiou, George S.
    Williams, Bryan
    JOURNAL OF HYPERTENSION, 2025, 43 (04) : 642 - 648
  • [43] Relationship of 24-Hour Mean Arterial Pressure with Systolic and Diastolic Blood Pressure in Hypertension: Insights from Ambulatory Blood Pressure Monitoring
    Karahan, Aysegul
    Zor, Utku
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2024, 28 (12) : 592 - 598
  • [44] Acute physical exercise and ambulatory blood pressure in resistant hypertension
    Saco-Ledo, Gonzalo
    Valenzuela, Pedro L.
    Almazan-Polo, Jaime
    Plaza-Florido, Abel
    Alejo, Lidia B.
    Bustos, Asuncion
    Rio-Garcia, Antia
    Galvez, Beatriz G.
    Rubio-Gonzalez, Esther
    Fiuza-Luces, Carmen
    Leon-Sanz, Miguel
    Boraita, Araceli
    Santos-Lozano, Alejandro
    Ruilope, Luis M.
    Lucia, Alejandro
    JOURNAL OF HYPERTENSION, 2025, 43 (03) : 445 - 455
  • [45] Trends in ambulatory blood pressure monitoring use for confirmation or monitoring of hypertension and resistant hypertension among the commercially insured in the U.S., 2008-2017
    Desai, Raj
    Park, Haesuk
    Dietrich, Eric A.
    Smith, Steven M.
    INTERNATIONAL JOURNAL CARDIOLOGY HYPERTENSION, 2020, 6
  • [46] Ambulatory blood pressure monitoring can unmask hypertension in patients with psoriasis vulgaris
    Bacaksiz, Ahmet
    Erdogan, Ercan
    Sonmez, Osman
    Sevgili, Emrah
    Tasal, Abdurrahman
    Onsun, Nahide
    Topukcu, Bugce
    Kulac, Beytullah
    Uysal, Omer
    Goktekin, Omer
    MEDICAL SCIENCE MONITOR, 2013, 19 : 501 - 509
  • [47] Clinical predictors and impact of ambulatory blood pressure monitoring in pediatric hypertension referrals
    Davis, Marguerite L.
    Ferguson, Michael A.
    Zachariah, Justin P.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (09) : 660 - 667
  • [48] Out-of-office blood pressure monitoring in defining and confirming true resistant hypertension
    Kollias, Anastasios
    Kyriakoulis, Konstantinos G.
    Stergiou, George S.
    HYPERTENSION RESEARCH, 2025, 48 (03) : 1246 - 1247
  • [49] Diagnosing Masked Hypertension Using Ambulatory Blood Pressure Monitoring, Home Blood Pressure Monitoring, or Both?
    Anstey, D. Edmund
    Muntner, Paul
    Bello, Natalie A.
    Pugliese, Daniel N.
    Yano, Yuichiro
    Kronish, Ian M.
    Reynolds, Kristi
    Schwartz, Joseph E.
    Shimbo, Daichi
    HYPERTENSION, 2018, 72 (05) : 1200 - 1207
  • [50] Ambulatory Blood Pressure Monitoring in Hemodialysis Patients with Intradialytic Hypertension
    Shafiee, Maryam
    Jahromi, Shahrokh Ezzatzadegan
    Jalali, Ghanbar Ali Raiss
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2020, 14 (02) : 126 - 132